Phase I Trial and Preclinical Data of ACT Using Neoantigen-Reactive TIL for Patients with Advanced Epithelial and ICB-resistant Solid Cancers
Immuno-Oncology and Technology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined